Back to Explorer
Chemicals & Materials

Non-Cyanide Gold Leaching Reagents Market Intelligence: Size, Share and Growth Outlook Through 2036

By chemistry, application, form, end use, sales channel, and region

By Brevintel Editor•September 2026•PDF + Excel

Market Size (2026)

$621M

Market Forecast (2036)

$1.2B

CAGR (2026-2036)

6.4%

Brevintel analysis values the non-cyanide gold leaching reagents market at USD 620.6 million in 2026 ($621M), with demand projected to reach USD 1154.1 million ($1.2B) by 2036 at a 6.4% CAGR. Mine operators convert technical interest into orders only after representative ore tests establish recovery, reagent use, residue behavior, and downstream compatibility. Thiosulfate reagents are estimated at 24.0% of chemistry in 2026, heap leaching at 26.0% of application, liquid reagent at 36.0% of form, gold mines at 55.0% of end use, and direct mine trials at 36.0% of sales channel. Country CAGRs range from Australia at 7.3% to Japan at 4.8% through 2036, with Ghana at 6.8%, Peru at 6.6%, Mexico at 6.4%, Canada at 6.2%, and the USA at 5.9%. EnviroGold Global Limited reported in January 2026 that 2025 work moved the NVRO Process into engineering readiness, while CSIRO documented in October 2025 that Goldstrike treated up to 13,000 metric tons of ore per day from 2014 to 2024. Notable suppliers include Draslovka a.s., Clean Mining Pty Ltd, NVRO Metals Limited, and Cycladex Ltd.

Non-Cyanide Gold Leaching Reagents Market Intelligence: Size, Share and Growth Outlook Through 2036

Key Market Trends & Insights

  • Headline cards list $621M, $1.2B, and 6.4% CAGR; the narrative path is USD 620.6 million in 2026 to USD 1154.1 million by 2036 at a 6.4% CAGR.
  • Thiosulfate reagents are estimated at 24.0% of chemistry in 2026; CSIRO documented in October 2025 that Goldstrike treated up to 13,000 metric tons of ore per day from 2014 to 2024.
  • Heap leaching is forecast at 26.0% of application in 2026; liquid reagent at 36.0% of form; gold mines at 55.0% of end use; and direct mine trials at 36.0% of sales channel.
  • Country CAGRs through 2036 span Australia 7.3%, Ghana 6.8%, Peru 6.6%, Mexico 6.4%, Canada 6.2%, the USA 5.9%, and Japan 4.8%.
  • EnviroGold Global Limited reported in January 2026 that 2025 work moved the NVRO Process into engineering readiness, and in March 2026 that Phase 2 Hecla Greens Creek testing achieved 99.46% gold recovery.
  • Geoscience Australia reported in August 2026 that gold accounted for 40% of 2025 mineral exploration expenditure; USGS estimated 160 metric tons of U.S. gold in 2025, with Nevada about 64%; Ontario and Quebec produced 68% of Canadian gold in 2024.
  • Draslovka reported in April 2026 that five new GLT testing licenses were signed during 2025; INEGI reported in February 2026 that Mexico’s gold output in December 2025 fell 16.8% year earlier.
  • UNDP documented in June 2026 a three-tier Ghana framework; Peru signed a June 2026 Switzerland memorandum on responsible artisanal gold; Japan’s METI listed Hishikari in October 2025 mine-safety awards.

Market Overview

Size, qualification, and commercial conversion

  • Brevintel analysis values the non-cyanide gold leaching reagents market at USD 620.6 million in 2026 ($621M), expanding to USD 1154.1 million ($1.2B) by 2036 at a 6.4% CAGR.
  • Headline cards list $621M, $1.2B, and 6.4%, matching the USD 620.6 million (2026) to USD 1154.1 million (2036) path across 2025–2036.
  • Mine operators convert technical interest into reagent orders only after representative ore tests establish recovery, reagent consumption, residue behavior, and downstream compatibility.
  • EnviroGold Global Limited reported in January 2026 that 2025 work moved the NVRO Process into engineering readiness, leaving site-scale recovery and residue performance as remaining commercial tests.
  • Mine access and installed recovery circuits determine how quickly alternative chemistry reaches field trials rather than how fast gold output grows in aggregate.
  • Australia’s metallurgical testing base supports that qualification work, but commercial conversion still occurs project by project after the alternative route survives site-specific testing.
  • General gold-production activity does not become reagent demand until laboratory and plant teams can show that a cyanide-free route fits the existing recovery circuit.
  • The 6.4% trajectory through 2036 is therefore a function of trial conversion and residue proof, not a uniform switch away from cyanide at every mine.

Industrial references versus site-by-site proof

  • CSIRO documented in October 2025 that its Goldstrike cyanide-free process treated up to 13,000 metric tons of ore per day from 2014 to 2024, giving thiosulfate chemistry an industrial operating reference.
  • An industrial reference still has to be translated into site approval because metallurgical teams must match reagent concentration with ore behavior and downstream recovery.
  • EnviroGold Global Limited reported in March 2026 that Phase 2 work on Hecla Greens Creek tailings achieved 99.46% gold recovery in structured testing.
  • High laboratory recovery does not replace residue, reagent-use, and circuit-compatibility evidence at the operating site before repeat purchasing begins.
  • Draslovka reported in April 2026 that five new GLT testing licenses were signed during 2025, showing that heap and related programs still enter through staged qualification.
  • Draslovka’s 2025 Annual Report describes real-time liquid-phase measurement of glycine and copper glycinate for operating control during dose adjustment.
  • Installed cyanide plants raise switching cost because ore-handling chemicals and recovery circuits already follow an existing flowsheet.
  • Brevintel analysis treats 2026–2036 growth as geographically uneven: the same 6.4% global CAGR coexists with country rates from 7.3% in Australia to 4.8% in Japan.

Market Dynamics

Lower-hazard processing and tailings openings

  • Lower-hazard processing expands mine trials because operators can screen alternative leach chemistry without immediately rebuilding a complete cyanide circuit.
  • Heap projects can screen eco-friendly beneficiation reagents with column tests that preserve percolation before a pad campaign begins.
  • Column programs expose clay response and reagent consumption before pad deployment, allowing mine teams to reject unsuitable chemistry without changing the complete plant flowsheet.
  • Difficult tailings create revenue openings for qualified alternative leach routes where conventional cyanide recovery has already left residual gold in residue.
  • The March 2026 Hecla Greens Creek Phase 2 result of 99.46% gold recovery shows how tailings programs can become a commercial test bed after laboratory recovery is documented.
  • January 2026 NVRO engineering-readiness reporting after 2025 work illustrates the remaining gap between process design and site-scale residue performance.
  • Direct mine trials remain the qualification route for precious-metal reagents that alter leach chemistry or recovery behavior at an operating site.
  • Trial programs link reagent dose with recovery and cycle time under representative feed, giving plant teams evidence that laboratory performance survives operating conditions.

Cyanide lock-in and switching requirements

  • Established cyanide systems raise switching requirements because operators already hold handling practices, recovery carbon circuits, and compliance routines around incumbent chemistry.
  • Thiosulfate leaching uses established sodium thiosulfate chemistry but requires a dedicated gold-recovery step that conventional carbon circuits may not provide.
  • United States mines retain substantial installed cyanide infrastructure that raises the proof required for switching, even where heap-leach and mill circuits are well documented.
  • Installed circuits provide representative feed and operating history, but they also raise the cost of a failed chemistry change.
  • Developers therefore need recovery and residue data from the actual site before modifying chemical handling or downstream recovery.
  • Ore variability forces each site to separate reagent performance from changing mineralogy, so local assay support is useful only if recovery gains survive the existing circuit.
  • Smaller processors struggle to fund equipment and maintain operator training once demonstration projects end, limiting conversion after a successful trial.
  • Reagent developers reach a durable trial pool only if dosing support and finance carry chemistry changes into operation rather than stopping at a laboratory campaign.

Segmentation Analysis

Chemistry

  • The market is assessed by chemistry, application, form, end use, sales channel, and region.
  • Chemistry includes thiosulfate reagents, glycine leaching reagents, thiourea systems, halide leaching systems, and proprietary non-cyanide blends.
  • By chemistry, the thiosulfate reagents segment is estimated to hold 24.0% in 2026 attributable to industrial operating references and a defined cyanide-free route.
  • CSIRO documented in October 2025 that Goldstrike treated up to 13,000 metric tons of ore per day from 2014 to 2024, supporting thiosulfate’s reference position.
  • Metallurgical teams must match thiosulfate concentration with ore behavior and downstream recovery before an industrial reference can translate into site approval.
  • Glycine leaching reagents, including programs associated with Draslovka GLT testing licenses, compete where liquid-phase control of glycine and copper glycinate can be measured in real time.
  • Thiourea systems, halide leaching systems, and proprietary non-cyanide blends remain in the toolkit where ore mineralogy or recovery-circuit constraints differ from a thiosulfate flowsheet.
  • A 24.0% thiosulfate share in 2026 does not make that chemistry universal; each mine still has to prove recovery and residue behavior on representative feed.

Application

  • Application covers heap leaching, CIL/CIP replacement, preg-robbing ores, refractory gold ores, and small-scale gold processing.
  • The application category is forecast to be led by heap leaching at 26.0% share in 2026 owing to staged qualification on representative coarse ore.
  • Heap projects can screen reagents with column tests that preserve percolation before a pad campaign begins, lowering the cost of rejecting unsuitable chemistry.
  • Draslovka reported in April 2026 that five new GLT testing licenses were signed during 2025, reinforcing heap and related qualification as an entry path.
  • Pad approval still requires coarse-ore data on recovery and reagent consumption under representative leach conditions before a campaign is authorized.
  • CIL/CIP replacement is a higher-friction application because conventional carbon circuits may not recover gold from thiosulfate or other cyanide-free pregnant solutions.
  • Preg-robbing ores and refractory gold ores keep alternative chemistry commercially relevant where incumbent cyanide recovery is incomplete or circuit-constrained.
  • Small-scale gold processing adds a separate trial pool, but operators still need dosing support that fits limited on-site chemical inventories.

Form, end use, and sales channel

  • Form includes liquid reagent, powder reagent, concentrate kit, and on-site generated reagent.
  • In 2026, liquid reagent is expected to lead the form category with 36.0% share driven by controllable addition during testwork and operating adjustment.
  • Mine laboratories use liquid extraction reagents where dose changes must follow solution chemistry during qualification, including glycine and copper glycinate measurement described in Draslovka’s 2025 Annual Report.
  • Liquid supply lets metallurgists revise dosage during early mine trials without rebuilding existing dry-mixing infrastructure, provided storage and handling controls match the qualification inventory.
  • End use covers gold mines, pilot plants, ESG-focused mining projects, and toll processors; gold mines are forecast to represent 55.0% in 2026 after a site validates recovery and flowsheet compatibility.
  • Operating mines compare reagent chemistry with existing mineral processing equipment before a successful test can become repeat consumption at commercial scale.
  • Sales channels include direct mine trials, specialty chemical suppliers, technology licensing, and mining reagent distributors.
  • Direct mine trials are projected to hold 36.0% share in 2026 attributable to ore-specific proof before technical interest becomes a repeat purchasing decision.

Regional Outlook

Upper-band trial markets

  • Australia and Ghana form the upper growth band because both provide practical routes from laboratory work into field testing through 2036.
  • Non-cyanide gold leaching reagent demand in Australia is projected to expand at 7.3% CAGR through 2036 because local test capacity supports staged field qualification.
  • Geoscience Australia reported in August 2026 that gold accounted for 40% of national mineral exploration expenditure during 2025, keeping ore-definition work close to operating sites.
  • Australian mine teams can use a broad metallurgical service base and beneficiation reagent programs for ore work at operating sites, shortening sample-shipping delays.
  • Ghana is forecast to grow at 6.8% CAGR through 2036 as safer processing programs move closer to mine operation for industrial and smaller operators.
  • UNDP documented in June 2026 that stakeholders validated a three-tier framework after identifying licensing complexity and weak district capacity in Ghana.
  • Non-cyanide gold leaching reagent demand in Peru is forecast to rise at 6.6% CAGR through 2036 attributable to cleaner processing programs that pair local technical partners with formalization.
  • Peru’s Ministry of Energy and Mines signed a cooperation memorandum with Switzerland in June 2026 to promote responsible artisanal and small-scale gold mining.

Installed-cyanide and concentrated-mine markets

  • Demand for non-cyanide gold leaching reagents in Mexico is anticipated to record 6.4% CAGR through 2036 supported by targeted projects in difficult feed.
  • INEGI reported in February 2026 that national gold output during December 2025 fell 16.8% from the same month a year earlier, keeping recovery losses visible to plant teams.
  • The Canadian market is expected to maintain 6.2% CAGR through 2036 driven by active mine capacity and technical qualification.
  • Natural Resources Canada reported in February 2026 that Ontario and Quebec produced 68% of national gold output during 2024, concentrating service demand for repeat ore testing.
  • Non-cyanide gold leaching reagent sales in the USA are forecast to expand at 5.9% CAGR through 2036 owing to targeted site trials against installed cyanide infrastructure.
  • The USA Geological Survey estimated 160 metric tons of gold production in 2025 and reported that Nevada accounted for about 64%.
  • Adoption of non-cyanide gold leaching reagents in Japan is estimated to expand at 4.8% CAGR through 2036 attributable to specialized research and mine-specific qualification.
  • Japan’s Ministry of Economy, Trade and Industry listed Hishikari as an operating gold and silver mine in its October 2025 national mine-safety awards, underscoring a narrow domestic trial base.

Competitive Landscape

Qualification programs and process specialists

  • Draslovka a.s., NVRO Metals Limited, Clean Mining Pty Ltd, and Cycladex Ltd are notable companies serving this market.
  • Competition separates glycine and related liquid-control chemistry from process-licensing routes that still have to prove site-scale recovery and residue performance.
  • Draslovka reported in April 2026 that five new GLT testing licenses were signed during 2025, and its 2025 Annual Report describes real-time liquid-phase measurement of glycine and copper glycinate.
  • EnviroGold Global Limited reported in January 2026 that 2025 work moved the NVRO Process into engineering readiness, with site-scale recovery and residue tests still outstanding.
  • The March 2026 Phase 2 Hecla Greens Creek result of 99.46% gold recovery is a structured-testing reference, not a substitute for operating-circuit conversion.
  • CSIRO’s October 2025 Goldstrike documentation of up to 13,000 metric tons of ore per day from 2014 to 2024 remains the principal industrial-scale cyanide-free operating reference cited in this market.
  • Clean Mining Pty Ltd and Cycladex Ltd compete as cyanide-free process specialists whose commercial conversion still depends on representative ore tests and downstream recovery fit.
  • Repeat purchasing still hinges on recovery, reagent use, residue behavior, and compatibility with installed gold-recovery circuits rather than on brochure claims about cyanide substitution.

Process licensors

  • NVRO Metals Limited
  • Clean Mining Pty Ltd
  • Cycladex Ltd

Specialty suppliers

  • Draslovka a.s.

Key Companies Covered

Draslovka a.s.
Clean Mining Pty Ltd
NVRO Metals Limited
Cycladex Ltd

Table of Contents

The complete report includes additional chapters, data tables, and company profiles beyond this preview.

1. Market Overview

  • Size to 2036 and ore-test conversion
  • Industrial references versus site proof

2. Market Dynamics

  • Lower-hazard trials and tailings openings
  • Cyanide lock-in and switching requirements

3. Segmentation Analysis

  • Chemistry, application, form, end use, and channel

4. Regional Outlook

  • Australia to Japan country CAGR spread
  • Exploration, production, and concentrated mine bases

5. Competitive Landscape

  • Process licensors and specialty suppliers

Frequently Asked Questions

Access the Complete Report

Get full access including detailed market analysis, competitive positioning, and strategic recommendations.

Related Reports

Explore the latest research from this industry.

Pine Oil Flotation Frothers Market Intelligence: Size, Share and Growth Outlook Through 2036

Published: September 2026

Sodium Cyanide Leaching Reagents Market Intelligence: Size, Share and Growth Outlook Through 2036

Published: September 2026

Oriented Strand Board Adhesives Market Intelligence: Size, Share and Growth Outlook Through 2036

Published: September 2026

Trailer Wiring Harnesses Market Intelligence: Size, Share and Growth Outlook Through 2036

Published: September 2026

Recommended Reports

Discover other market intelligence selected based on relevance and market trends.

Negative Pressure Wound Therapy Market Intelligence: Size, Share and Growth Outlook Through 2035

Published: September 2026

Multitasking Machine Tools Market Intelligence: Size, Share and Growth Outlook Through 2036

Published: September 2026

mRNA Vaccines Market Intelligence: Size, Share and Growth Outlook Through 2035

Published: September 2026

Mineralized Biochar Blends Market Intelligence: Size, Share and Growth Outlook Through 2036

Published: September 2026